Работы, на которые ссылается эта работа

Работ: 20

Работа: The Role of Chemotherapy in Triple Negativ Breast Cancer

Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
Rebecca Dent, Maureen Trudeau, Kathleen I. Pritchard +7
Статья2007Цитирований: 5
ABI
Triple-Negative Breast Cancer: Molecular Subtypes and New Targets for Therapy
Brian D. Lehmann, Jennifer A. Pietenpol, Antoinette R. Tan
Статья2015Цитирований: 4
ABI
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar, Lijun Zhang, Michael Untch +34
Обзорная статья2014Цитирований: 4
ABI
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann, Joshua A. Bauer, Xi Chen +4
Статья2011Цитирований: 4
ABI
Globocan 2000 : cancer incidence, mortality and prevalence worldwide
Jacques Ferlay, Paola Pisani, Donald Maxwell Parkin
Книга2001Цитирований: 3
ABI
Molecular Subtype of Breast Cancer Metastases Significantly Influences Patient Post-Relapse Survival
Nicholas P. Tobin, J. Chuck Harrell, Søren Brage +5
Статья2014Цитирований: 3
ABI
Pathological complete response in breast cancer – Authors' reply
Patricia Cortazar, Charles E. Geyer, Luca Gianni +2
Другое2015Цитирований: 3
ABI
Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
Gϋnter von Minckwitz, Michael Untch, Eveline Nüesch +20
Статья2010Цитирований: 3
ABI
Characteristics of triple-negative breast cancer
Tim C. de Ruijter, Jürgen Veeck, Joep P.J. de Hoon +2
Обзорная статья2010Цитирований: 3
ABI
Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors
Valentina Guarneri, Kristine Broglio, Shu‐Wan Kau +8
Статья2006Цитирований: 3
ABI
Triple-Negative Breast Cancer: An Unmet Medical Need
Clifford A. Hudis, Luca Gianni
Обзорная статья2011Цитирований: 3
ABI
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Thérese Sørlie, Charles M. Perou, Robert Tibshirani +14
Статья2001Цитирований: 3
ABI
Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer
Mark Ayers, W. Fraser Symmans, James Stec +15
Статья2004Цитирований: 3
ABI
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Roman Rouzier, Charles M. Perou, W. Fraser Symmans +13
Статья2005Цитирований: 3
ABI
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gabriel N. Hortobágyi
Статья2012Цитирований: 3
ABI
Triple Negative Breast Cancer Pathologic Diagnosis and Current Chemotherapy Treatment Options
Bernardo L. Rapoport, Simon Nayler, Georgia Demetriou +2
Статья2014Цитирований: 3
ABI
Survival in triple-negative breast cancer (TNBC): Evidence from the SEER database 2010-2011.
Rebecca Dent, Paul N. Mainwaring, Tira J. Tan +4
Статья2015Цитирований: 3
ABI
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess +10
Статья2023Цитирований: 3
ABI
Gene expression profiling predicts clinical outcome of breast cancer
Laura Van 't Veer, Hongyue Dai, Marc Van De Vijver +67
Статья2002Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 1
ABI